2Assieot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsisi and infection[J]. Lancet, 1999,341:515--551.
3Maruna P, Nedelnikova K, Curlich R. Physiology and genetics of procalitonin[J]. Physiol Res,2000,49:S57.
4Weglohner W, Agay D, Bohuon C,et al. Production of procalcitonin (PCT) in non--thyroidal tissue after LPS injection[J]. Horn Metab Res,2003,35:290.
5Oberhoffer M, Stonanns I, Russwurm S, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsisralated cytokines in vitro[J]. J Lab Clin Med, 1999,134(1):49--55.
7Anonymous. American Society of Anesthesiologists 1999 annual meeting. Dallas, Texas, USA. October 9-- 13,1999, Abstracts[J]. Anesthesiology, 1999,91(3A Suppl) : A1-- A1523.
9Oczenski W, Fizgerald RD, Schwarz S, et al. Procalcitonin : a new parameter for the diagnosis of bacterial infection in the peri--operative period[J]. Eur J Anasth,1998,15(2) :202--209.
10Wanner GA, Keel M, Steckhoizer U, et al. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure,and mortality in injured patients[J]. Crit Care Med, 2000,28(4) :950--957.
二级参考文献48
1[4]Whang K T, Vath S D, Becker K L, et al. Procalcitonin and proinflammatory cytokine interactions in sepsis[J]. Shock, 2000, 14(1): 73-78.
2[5]Oberhoffer M, Stonans I, Russwurn S, et al. Procalcitonin expression in human peripheral blood mononuclear cell and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro[J]. J Lab Clin Med, 1999, 134(1): 49-55.
3[6]Oberhoffer M, Voglsang H, Rubwurm S, et al. Outcome prediction by traditional and new markers of inflammation in patients with sepsis[J]. Clin Chem Lab Med, 1999, 37(3): 363-368.
4Suresh Karne MD, PhD, Fred S, et al. Etiopathogenesis of acute pancreatitis[ J]. Surg Clin North Am,1999,79(4) :699-710.
5Andreas Oberholzer M D, Caroline Oberholzer M D ,Lyle L, et al. Cytokine singling-regulation of the immune response in normal and critically ill states [ J ]. Crit Care Meal, 2000, 28 ( 4 ) :4 -12.
6Steven M, Opal M D, Vera A,et al. Anti-inflammatory cytokines[J].Chest.2000.117(4) :1162-1172.
7Roger C, Bone MD. Immunologic dissonance : A continuing evolution in our understanding of the systemic inflammatory response syndrome (SlRS) and the multiple organ dysfunction syndrome (MODS) [J]. Ann Inter Med,1996,125(8) :680-685.
8Faist E, Schinkel C, Zimmer S. Update on the mechanisms of immune suppression of injury and immune modulation [J].World J Surg, 1996,20 (4) :454459.
9Norman J, Yang J, Fink G, et al. Severity and mortality of experimental pancreatitis are dependent on interleukin-1 converting enzyme(ICE) [J]. J Interferon Cytokine Res,1997,17(2) :113-118.
10Fink G, Yang J, Carter G, et al. Acute pancreatitis induced enzyme release and necrosis are attenuated by IL-1 antagonism through an indirect mechanism[J]. J Surg Res, 1997,67 ( 1 ) :94-97.
